Nalls Sherbakoff Group’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	$28.3K	Buy	317 +67	+27%	+$5.98K	0.03%	210
2023 Q3	$18.3K	Hold	250	–	–	0.02%	228
2023 Q2	$21K	Hold	250	–	–	0.02%	223
2023 Q1	$18.7K	Buy	+250	New	+$18.7K	0.02%	235
2018 Q4	$18K	Buy	+250	New	+$18K	0.03%	223